Viking Global Investors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-846,562
Closed -$192M 89
2022
Q1
$192M Sell
846,562
-143,009
-14% -$33.6M 0.78% 37
2021
Q4
$267M Buy
989,571
+67,979
+7% +$16.8M 0.77% 37
2021
Q3
$223M Sell
921,592
-677,062
-42% -$171M 0.61% 54
2021
Q2
$379M Buy
1,598,654
+340,115
+27% +$77.5M 1.15% 33
2021
Q1
$276M Buy
1,258,539
+1,148,541
+1,044% +$230M 0.82% 40
2020
Q4
$19.2M Sell
109,998
-390,266
-78% -$67.4M 0.05% 88
2020
Q3
$80.9M Buy
+500,264
New +$79.3M 0.29% 66
2016
Q2
Sell
-783,428
Closed -$78.8M 63
2016
Q1
$78.8M Sell
783,428
-2,951,508
-79% -$283M 0.35% 41
2015
Q4
$397M Sell
3,734,936
-2,147,162
-37% -$222M 1.5% 21
2015
Q3
$548M Buy
+5,882,098
New +$608M 2.1% 15

Other funds holding LH

Viking Global Investors's LH Position: Q2 2022 in Review

Viking Global Investors sold out of Labcorp (LH) in Q2 2022, closing a stake of 846,562 shares — an estimated $192M sold.

Viking Global Investors first reported a position in LH in Q3 2015 and held it in 10 quarters. The position peaked at $548M in Q3 2015. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • Viking Global Investors reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
  • Viking Global Investors sold 846,562 Labcorp shares in Q2 2022, an estimated $192M.
  • Viking Global Investors first reported a position in Labcorp in Q3 2015 and held it in 10 quarters.
  • Viking Global Investors's Labcorp position peaked at $548M in Q3 2015.
  • 966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Viking Global Investors's 13F filing for Q2 2022, filed 15 Aug 2022.